The Latest Breaking News from CI

Cigna Corp (NYSE: CI) is poised to benefit from the launch of bioequivalent Humira in July 2023, according to Morgan Stanley.

GARP is a strategy to blend the best parts of value and growth investing. It's particularly apt as it will allow investors to identify the top growth stocks trading at attractive valuations such as Cigna (CI), Freeport McMoran (FCX), and Micron (MU).

U.S. Treasury yields rose to multi-year highs earlier this month. And rising Treasury yields along with the Fed’s interest rate hikes bode well for life insurance companies. Thus, we think the shares of fundamentally sound life insurance companies Anthem (ANTM), Cigna Corp. (CI), UnitedHealth Group (UNH), Molina Healthcare (MOH), and…

Demand for health insurance policies has soared over the past couple of years and is projected to continue rising amid heightened health awareness in the post-pandemic era. Thus, we think the stocks of quality health insurance companies Humana (HUM), Cigna (CI), Centene (CNC), Molina Healthcare (MOH), and Anthem (ANTM) could…

The stock market closed in the red yesterday as concerns about inflation again spooked investors. Blue-chip stocks are known for their rich history of sustained gains. Hence, we think blue-chip names Walmart (WMT), AbbVie (ABBV), Cigna Corp (CI), International Business Machines (IBM), and Johnson & Johnson (JNJ), whose stocks have…

Cigna Corp (NYSE:CI) posted 1Q22 adjusted EPS well above expectations on enterprise-wide growth, with a particularly solid performance in specialty pharmacy and better than expected MCR on lower testing and treatment costs.  The company raised FY22 guidance on 1Q outperformance. The analysts raised the price target to $272 from $235, with a Sector Perform rating. …

  Cigna (NYSE:CI) reported its Q1 earnings results on Friday, May 6, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Cigna beat estimated earnings by 16.02%, reporting an EPS of $6.01 versus an estimate of $5.18.

Cigna (NYSE:CI) has outperformed the market over the past 15 years by 4.13% on an annualized basis producing an average annual return of 11.01%. Currently, Cigna has a market capitalization of $83.55 billion.

Cigna Corp (NYSE:CI) reports Q1 total revenues of $44.12 billion, +7.6% Y/Y, ahead of the consensus of $43.41 billion. Cigna brought in $1.18 billion in earnings, up from $1.16 billion a year ago.  Q1 adjusted EPS reached $6.01 compared with $4.73 a year ago, beating the consensus of $5.18.  By the end of…